HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign
NAPLES, Fla., June 12, 2024 (GLOBE NEWSWIRE) -- via IBN – HealthLynked Corp. (OTCQB: HLYK), a leading provider of healthcare...
Month: June 2024
Victory Square Company Hydreight Adds Another National Wellness Medspa Franchise Using Its White Label Solution
VANCOUVER, British Columbia, June 12, 2024 (GLOBE NEWSWIRE) -- Victory Square Technologies Inc. (“Victory Square” or the “Company”) (CSE:VST) (OTC:VSQTF)...
Singing Machine to Acquire AI Logistics Tech, SemiCab
DENVER, Colo., Jun 12, 2024 (247marketnews.com)- The Singing Machine Company, Inc. (NASDAQ:MICS) is acquiring SemiCab, Inc., an artificial freight optimizing intelligence...
Accuray Announces Approval of the Accuray Precision® Treatment Planning System by China’s National Medical Products Administration
MADISON, Wis., June 12, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the registration dossier for the Accuray...
XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals’ Sale of its Priority Review Voucher
EMERYVILLE, Calif., June 12, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today it has...
XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals’ Sale of its Priority Review Voucher
EMERYVILLE, Calif., June 12, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today it has...
XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals’ Sale of its Priority Review Voucher
EMERYVILLE, Calif., June 12, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today it has...
Vivos Therapeutics Closes $7.5 Million At-The-Market Private Equity-Backed Investment and Launches Strategic Marketing and Distribution Alliance
Alliance with Sleep Treatment Provider in Colorado Marks Critical Pivot in Vivos’ Marketing and Distribution Model Aimed at Enhancing Revenue...
Real Launches Real Partners to Empower Agents With Industry-Leading Tools and Services for Increased Competitive Advantage
Real Partners grants service providers exclusive access to the brokerage’s thriving agent network, amplifying business reach Contacts Investor inquiries, please...
Lantern Pharma Receives Certificate of Patent from Japanese Patent Office (JPO) for Composition of Matter Covering Drug Candidate LP-284
LP-284 is currently in a Phase 1 clinical trial, having been developed with guidance from Lantern’s AI platform, RADR®, as...
LINDBLAD EXPEDITIONS HOLDINGS, INC. EXPANDS OPERATIONS IN CORE GALÁPAGOS MARKET WITH ADDITION OF TWO NEW VESSELS
Bookings to Open Later this Month, with Two Newly Added Purpose-Built Ships to Set Sail in Early 2025 Lindblad Expeditions...
Kelly Completes Sale of Ayers Group, a Division of KellyOCG, to Keystone Partners
TROY, Mich., June 12, 2024 (GLOBE NEWSWIRE) -- Kelly (Nasdaq: KELYA, KELYB), a leading global specialty talent solutions provider, has...
Keystone Partners Announces Acquisition of The Ayers Group
BOSTON, June 12, 2024 /PRNewswire/ -- Keystone Partners, a Silver Oak Services Partners LLC portfolio company, announced that it has...
Baozun Announces Results of Annual General Meeting of Shareholders
SHANGHAI, June 12, 2024 /PRNewswire/ -- Baozun Inc. (NASDAQ: BZUN and HKEX: 9991) ("Baozun" or the "Company"), a leading brand...
Orezone Intersects 113.74 g/t Gold Over 8.00m in Ongoing Exploration and Provides Project Update
VANCOUVER, British Columbia, June 12, 2024 (GLOBE NEWSWIRE) -- Orezone Gold Corporation (TSX: ORE, OTCQX: ORZCF) (the “Company” or “Orezone”)...
Laser Photonics Launches SaberTech Line of Next Generation Laser Cutting Systems
Built With Turbo Piercing Technology for Lower HAZ Contacts Investor Relations Contact: laser@haydenir.com Contact: Karla Kizzort Laser Photonics Corporation kkizzort@laserphotonics.com...
Cyngn Highlights Its Proprietary Computer Vision Advancements with NVIDIA Accelerated Computing
MENLO PARK, Calif., June 12, 2024 /PRNewswire/ -- Cyngn Inc. (Nasdaq: CYN) has announced progress of its proprietary computer vision...
Clearside Biomedical’s Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at the Clinical Trials at the Summit Meeting
- Broad Use of Suprachoroidal Injection Platform Highlighted Across Retinal Indications -- Robust Safety Profile and Encouraging Efficacy Data Reported...
Riot Comments on Bitfarms’ Adoption of Shareholder-Unfriendly Poison Pill
Poison Pill Comes Just Days After Riot Privately Urged Bitfarms to Consult with Riot and Other Large Shareholders on New...
Athira to Host Webinar Highlighting Potential for Fosgonimeton to Protect and Preserve Neuronal Health in Mild-to-Moderate Alzheimer’s Disease Patients
Company to provide overview of Phase 2/3 LIFT-AD clinical trial of fosgonimeton in mild-to-moderate Alzheimer’s disease (AD); LIFT-AD topline data...
Altair’s Leading Computational Intelligence Technology Drives NYYC American Magic Team’s Quest to Win the 37th America’s Cup
TROY, Mich., June 12, 2024 /PRNewswire/ -- Altair (Nasdaq: ALTR), a global leader in computational intelligence, is thrilled to showcase the highlights...
Aldeyra Therapeutics to Host Investor Roundtable Q&A
Event Scheduled for Thursday, June 20 at 8:00 a.m. ET Contacts Investor & Media: David Burke Tel: (917) 618-2651 investorrelations@aldeyra.com...
Vertex Acquires Artificial Intelligence Tax Capabilities from Ryan, LLC
KING OF PRUSSIA, Pa., June 12, 2024 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), a global provider of...
Taysha Gene Therapies to Present Clinical Data from Both REVEAL Phase 1/2 Trials During Company-Hosted Webcast and at 2024 IRSF Rett Syndrome Scientific Meeting
Company to host webcast on Tuesday, June 18, 2024, at 8:00 AM Eastern TimeOral presentation by Elsa Rossignol, M.D., FRCP, FAAP,...
Embrace the Spirit of Summer and Create Shareable Moments with Good Supply Cannabis
TORONTO, June 12, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a leading global lifestyle and consumer...
SS&C Expands Fund Administration Business in India with GIFT City Office
WINDSOR, Conn., June 12, 2024 /PRNewswire/ -- SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) is expanding its global footprint with a...
Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity under Strategic Partnership with Pfizer
Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity under Strategic Partnership...
Avidity Announces Unprecedented AOC 1020 Data from Phase 1/2 FORTITUDE™ Trial Demonstrating Greater Than 50 Percent Reduction in DUX4 Regulated Genes and Trends of Functional Improvement in People Living with Facioscapulohumeral Muscular Dystrophy
Avidity plans to accelerate the initiation of registrational cohorts in FORTITUDE™ trial Delpacibart braxlosiran (AOC 1020), the first investigational therapy to...
Riot Comments on Bitfarms’ Adoption of Shareholder-Unfriendly Poison Pill
Poison Pill Comes Just Days After Riot Privately Urged Bitfarms to Consult with Riot and Other Large Shareholders on New...
REGENXBIO Announces Leadership Transition
ROCKVILLE, Md., June 12, 2024 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that Curran Simpson, Chief Operating Officer, has...
Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity under Strategic Partnership with Pfizer
Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity under Strategic Partnership...
Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity under Strategic Partnership with Pfizer
Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity under Strategic Partnership...
Singing Machine to Acquire SemiCab, a Leading AI Logistics Technology Company
SemiCab Generated $6 Million Revenue in 2023Fort Lauderdale, FL, June 12, 2024 (GLOBE NEWSWIRE) -- The Singing Machine Company, Inc....
Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity under Strategic Partnership with Pfizer
Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity under Strategic Partnership...
ImmunoPrecise Antibodies Ltd. Subsidiary BioStrand Receives Prestigious 2024 Impact Award for Groundbreaking LENSai™ Technology
Contacts Investor contact: investors@ipatherapeutics.com ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“ImmunoPrecise” or “IPA” or the “Company”), a leader in AI-driven biotherapeutic...
Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity under Strategic Partnership with Pfizer
Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity under Strategic Partnership...
F5 Study: Enterprises Plowing Ahead with AI Deployment Despite Gaps in Data Governance and Security Concerns
Contacts Jenna Becker F5 (415) 857-2864 j.becker@f5.com Holly Lancaster WE Communications (415) 547-7054 hluka@we-worldwide.com F5 (NASDAQ: FFIV) today released a...
Dorman Products announces the grand opening of an additional USA-based drive shaft manufacturing facility
COLMAR, Pa., June 12, 2024 (GLOBE NEWSWIRE) -- Dorman Products, Inc. (NASDAQ:DORM) is proud to announce the grand opening of...
Dianthus Therapeutics Announces FDA Clearance to Initiate Phase 2 Trial of DNTH103 in Multifocal Motor Neuropathy (MMN)
Top-line results from Phase 2 MoMeNtum trial in Multifocal Motor Neuropathy anticipated in 2H 2026Building a neuromuscular franchise with DNTH103...
Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity under Strategic Partnership with Pfizer
Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity under Strategic Partnership...